Virology Market is expected to reach US$ 5,276.48 Million by 2028

Published Date: 20 Sep 2021

Report : Virology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Diagnostic Test, Viral Infection Controlling Techniques, Antiviral Therapeutics, and Interferons); Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infection, and Others); End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, and Research and Academic Institutes) and Geography

Diagnostic Test Segment to Lead Virology Market during 2021–2028

 

According to our latest study on “Virology Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, and End User,” the market is projected to reach US$ 5,276.48 million by 2028 from US$ 4,108.27 million in 2021; it is expected to register a CAGR of 3.6% from 2021 to 2028..

 

Based on type, the virology market is subsegmented into diagnostic tests, viral infection controlling techniques, antiviral therapeutics, and interferons. The diagnostic tests segment is expected to hold the largest market share in 2021. However, the viral infection controlling techniques segment is expected to register the highest CAGR during the forecast period.

 

Abbott; Johnson & Johnson Services, Inc.; F. Hoffmann-LA Roche Ltd.; Thermo Fisher Scientific, Inc.; Qiagen; Illumina, Inc.; Siemens AG; GlaxoSmithKline Plc; Gilead Sciences, Inc.; and AbbVie, Inc. are among the leading companies operating in the virology market.

Virology Market, by Region, 2021 (%)
Virology Market, by Region, 2021 (%)

The virology market is segmented on the basis of type, application, and end user. Based on type, the market is further segmented into diagnostic tests, viral infection controlling techniques, antiviral therapeutics, and interferons. Based on application, the market is segmented into skin and soft tissue infections, respiratory tract infections, Gastro Intestine (GI) tract infections, sexually transmitted diseases, urinary tract infections, and others. Based on end user, the market is segmented hospitals, diagnostic laboratories, pharmaceutical and biotechnological companies, and research and academic institutes. On the basis of geography, the virology market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and Rest of APAC), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and Rest of MEA), and South and Central America (Brazil, Argentina, and Rest of SCAM).

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Download Free PDF Brochure